FindTrial
Sign In

Covid 19 omicron variant related infections in the cancer patients admitted to the ICU

To evaluate the outcomes of SARS-CoV2 omicron variant related infections in the oncological patients admitted to the ICU

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2022/09/045299
Enrollment
20
Registered
2022-09-07
Start date
Unknown
Completion date
Unknown
Last updated
2024-11-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: 4- Measurement and Monitoring Health Condition 2: D499- Neoplasm of unspecified behavior of unspecified site Health Condition 3: B972- Coronavirus as the cause of diseases classified elsewhere

Interventions

None listed

Sponsors

Tata Memorial Hospital
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: All oncological patients admitted to the Intensive Care unit in TMH with Covid-19 confirmed by a positive rtPCR for SARS-CoV-2.

Exclusion criteria

Exclusion criteria: Post Bone Marrow transplant

Design outcomes

Primary

MeasureTime frame
demographics, primary diagnosis, treatment modality such as surgical or chemo or radiation, covid vaccination status, indication for ICU admission, severity and type of Covid related disease and associated systemic illness, length of stay in ICU, duration and type of ICU interventions such as mechanical ventilation, renal replacement therapyTimepoint: ICU outcome and hospital outcome at 30 days—

Secondary

MeasureTime frame
severity of illness and mortality in cancer patients in the ICU infected with the omicron variantTimepoint: ICU outcome and hospital outcome at 30 days—

Countries

India

Contacts

Public ContactDr J V Divatia

Tata Memorial Hospital

jdivatia@yahoo.com02224177041

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026